Administration of anti‐IL‐17RA mAb significantly inhibited the key phosphorylated proteins of the NF‐kB and MAPK pathways in SSc DFs that were upregulated by rChi3L1 (Figure S11A, Supporting Information). This evidence concerns the gene NFKB1 and systemic sclerosis.